Search clinical trials for: prostaglandin E2 (PGE2)

Total 414 results

Ain Shams University
North West Armed Forces Hospital

Completed

Prostin and Propess in Induction of Labor

Labor Pain

Saudi Arabia
Danish Headache Center

Completed

EP4-receptor Antagonism and Prostaglandin E2 (PGE2) in a Human Headache Model

Headache, Migraine

Denmark
University Hospital, Basel, Switzerland

Recruiting

Urinary Prostaglandin as a Potential Predictive Marker for Thiazide-induced Hyponatremia (PROPHECY)

Thiazide-induced Hyponatremia (TIH)

Switzerland
Tempest Therapeutics

Active, not recruiting

Phase 1a/1b Study of TPST-1495 as a Single Agent and in Combination With Pembrolizumab in Subjects With Solid Tumors

Colorectal Cancer | Solid Tumor | Gastric Adenocarcinoma | Non Small Cell Lung Cancer | Squamous Cell Carcinoma of Head and Neck | Endometrial Cancer | Urothelial Carcinoma | Gastroesophageal Junction Adenocarcinoma | Solid Tumors With PIK3Ca Mutation

United States
Rottapharm Biotech
Agenus Inc.

Active, not recruiting

A Phase Ib/IIa Study of CR6086 in Combination With Balstilimab in pMMR-MSS Metastatic Colorectal Cancer Patients

Solid Tumor | Metastatic Microsatellite-stable Colorectal Cancer | Mismatch Repair Protein Proficient | Refractory Metastatic Colorectal Cancer

Italy
Mansoura University

Completed

Single Versus Double Dose Intra-vaginal Prostaglandin E2 "Misoprostol" Prior Abdominal Myomectomy

Prostaglandin E2 "Misoprostol" Prior Abdominal Myomectomy
Samsung Medical Center
Samsung Biomedical Research Institute

Completed

Urinary Nerve Growth Factor (NGF), Prostaglandin E2 (PGE2)and Adenosine Triphosphate (ATP): Potential Biomarkers in Overactive Bladder Patients

Overactive Bladder

Korea, Republic of
Zeynep Kamil Maternity and Pediatric Research and...

Completed

Early Amniotomy After Vaginal Prostaglandin E2 for Induction of Labor at Term: a Randomized Clinical Trial (PGE2)

Early Amniotomy, Unfavorable Cervix

Turkey
Frank A. Bucci, Jr., M.D.
Allergan

Completed

A Comparison of Prostaglandin E2 (PGE2) Inhibition of Acuvail(Ketorolac 0.45%), Xibrom (Bromfenac 0.09%)and Nevanac (Nepafenac)in Patients Undergoing Phacoemulsification

Cataracts
Vanderbilt University Medical Center
UCB Pharma

Completed

Urinary Prostaglandin E Metabolite (PGE-M), A Metabolite of Prostaglandin E2 (PGE2): A Novel Biomarker of Crohn's Disease Activity

Crohn's Disease

United States
Nilratan Sircar Medical College

Completed

Comparison of Misoprostol and Prostaglandin E2 (PGE2) Gel for Induction of Labour in Premature Rupture of Membranes at Term

Premature Rupture of Membranes at Term

India
Danish Headache Center

Completed

Headache Inducing Characteristics and Possible Changes in Cerebral Blood Flow After Administration of PGE2

Migraine | Headache

Denmark
Wolfson Medical Center

Unknown

A Trial of Prostaglandin E2 Tablets Versus Foley Catheter for Labor Induction

Labor, Induced

Israel
National Institute of Dental and Craniofacial Research...

Completed

Celebrex for Pain Relief After Oral Surgery

Facial Pain

United States
Università degli Studi di Brescia

Completed

NSAIDs and PGE2 Levels in Vitrectomy Patients

Vitreous Inflammation
Health Decisions
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

A Dose-finding Study to Evaluate the Effect of a Contraceptive Vaginal Ring, Releasing Nestorone® and Estradiol, on Cycle Control, Ovulation Inhibition, and Pharmacokinetics in Normal Cycling Women

Suppression of Ovulation

United States
Genexine, Inc.

Completed

Study to Evaluate Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of GX-E2 in Healthy Subjects (GX-E2-P1)

Healthy

Korea, Republic of
Organon and Co

Completed

Bioequivalence of Nomegestrol Acetate (NOMAC) and Estradiol (E2) in Commercial Versus Phase 3 Pivotal Clinical Batches of NOMAC-E2 Tablets (P06328)

Healthy Postmenopausal Females
Bayer

Completed

Julina Post-marketing Surveillance for Climacteric Symptoms in Japan (JULINA-CLIMA)

Osteoporosis, Postmenopausal

Japan
Bayer

Completed

Julina Post-marketing Surveillance for Postmenopausal Osteoporosis in Japan

Osteoporosis, Postmenopausal

Japan
CytoCore, Inc.
University Hospitals Cleveland Medical Center

Completed

Adequacy and Efficacy of the e2TM Cervical Cell Collector Compared to Standard Spatula/CytoBrush Technique.

Colposcopy | Biopsy

United States
Instituto de Cardiologia do Rio Grande do Sul

Completed

Polyphenols Supplementation on Prostaglandin E2 in Women - Randomized Clinical Trial

Inflammatory Disorder of the Cardiovascular System
University Medical Centre Maribor

Not yet recruiting

Propess Versus Prostin for Induction of Labour in Women With Term PROM (PESTIBOR)

Induction of Labour | Premature Rupture of Membranes at Term
Ondokuz Mayıs University

Completed

Salivary C1P and PGE2 Levels in Periodontitis Patients With T2DM and Effect of Non-Surgical Periodontal Treatment

Periodontitis | Type 2 Diabetes

Turkey
Bayer

Completed

Wellnara Post-marketing Surveillance in Japan (WELLNARA)

Osteoporosis, Postmenopausal

Japan
University of Trieste

Completed

PGE2 Levels in Patient Treated With NSAIDs

Ocular Inflammation

Italy
Akdeniz University

Completed

The Impact of Estrogen Administration Duration in Hormonally Prepared Frozen Embryo Transfer Cycles

Duration of Estrogen Administration

Turkey
Oregon Health and Science University
Society of Family Planning

Completed

The Effects of a Prostaglandin Inhibitor on Ovulation and the Menstrual Cycle

Ovulation (Follicular Rupture Yes/no) | Menstrual Cycles (Total Length, Bleeding Days) | Gonadotropin and Ovarian Hormone Levels (FSH, LH, E2, P)

United States
Hanoi Obstetrics and Gynecology Hospital
Mỹ Đức Hospital

Recruiting

DOuble-BAlloon Versus PROstaglandin E2 for Cervical Ripening in Low Risk Pregnancies (DOBA-PRO)

Induction of Labor

Vietnam
Instituto de Cardiologia do Rio Grande do Sul

Completed

Increase of Prostaglandin E2 in Reversal of Ductal Constriction After Dietary Restriction of Polyphenols

Pregnancy Complications
AbbVie

Active, not recruiting

Long-Term Safety Study of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women

Uterine Fibroids | Heavy Menstrual Bleeding

United States, Puerto Rico
Vanderbilt University Medical Center

Withdrawn

Prostaglandin E2 as a Critical Mediator of Sex Disparities in Asthma

Asthma

United States
Isala
Merck Serono International SA

Unknown

Predicting Ovarian Response in Artificial Insemination With Low Stimulation

Subfertility

Netherlands
Zeynep Kamil Maternity and Pediatric Research and...

Completed

Combined Foley Catheter Balloon and PGE2 Vaginal Ovule for Induction of Labor at Term: A Randomized Study

Unfavorable Cervix, Cervical Ripening

Turkey
Troels Wienecke

Completed

Prostaglandin E2 in Migraine Suffers Without Aura.

"Migraine-like" Headache

Denmark
Bayer
University of California, San Francisco; Laboratorium für Klinische Forschung; Diagnostic Cytology Laboratory

Completed

Endometrial Safety Study

Postmenopause

Mexico, United States, Italy, Denmark, Austria, Argentina, Brazil, Russian Federation
Kyoto University, Graduate School of Medicine
National Institute of Biomedical Innovation

Terminated

Therapeutic Study of ONO-4819CD for Ulcerative Colitis

Ulcerative Colitis

Japan
Center for Epidemiology and Health Research, Germany
Merck Sharp & Dohme LLC; Theramex

Completed

Prospective Controlled Cohort Study on the Safety of a Monophasic Oral Contraceptive Containing Nomegestrol Acetate (2.5mg) and 17ß-estradiol (1.5mg) (PRO-E2)

Contraception

Germany
Boston Pharmaceuticals

Completed

Study to Determine the Relative Bioavailability, Single and Repeat Dose Pharmacokinetics, Safety and Tolerability of BOS172767 Enantiomers in Healthy Subjects

Healthy Participants

United Kingdom
University Hospital, Toulouse

Completed

Comparison Between 25 µg Vaginal Misoprostol vs Slow Release Pessary PGE2 (CYTOPRO)

Delivery Uterine

France
Nilratan Sircar Medical College

Completed

Comparison of Misoprostol and PGE2 Gel for Induction of Labour in Women With Premature Rupture of Membranes at Term

Premature Rupture of Membranes at Term

India
Steven M Rowe

Completed

G551D Observational Study- Expanded to Additional Genotypes and Extended for Long Therm Follow up (GOAL-e2) (GOAL- e2)

Cystic Fibrosis

United States
Bayer

Completed

Cycle Control and Safety of E2-DRSP

Contraceptive, Oral, Hormonal

Germany
Nanjing University

Unknown

GnRH Agonist (GnRHa) Withdrawal at Late Stage of Long Protocol and the Incidence of Ovarian Hyper-stimulation

Infertile High-risk Patients With Polycystic Ovaries

China
Organon and Co
CRS Mannheim GmbH

Completed

A Trial to Assess the Pharmacokinetic Profile (e.g., Uptake, Distribution and Excretion of a Substance in the Body) of Nomegestrol Acetate (NOMAC), Estradiol (E2) and Estrone (E1) After Multiple and Single Dose Administration of the Combined Oral Contraception NOMAC-E2 (COMPLETED)(P05822)

Healthy
General Hospital of Ningxia Medical University

Completed

The Effect of Anesthetic Technique on VEGF-C and PGE2

Uterine Leiomyomas
National Institute of Allergy and Infectious Diseases...

Completed

Chiron Corp HCV E1/E2 Vaccine

Hepatitis C

United States
Centre Hospitalier Universitaire, Amiens

Recruiting

Efficacy and Safety of Oral Misoprostol 25 μg vs. Vaginal Dinoprostone in Induction of Labor at Term (MISODINO)

Cesarean Section | Vaginal Delivery | Induction of Labor

France
NHS Lothian

Unknown

PGE2/IL-22 Pathway in Various Forms of Eczema

Eczema
Health Decisions
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Unknown

Study of Efficacy, Cycle Control, and Safety of a NES-E2 Contraceptive Vaginal Ring

Female Contraception | Healthy Women

United States

Search clinical trials for: prostaglandin E2 (PGE2)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uganda

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations